AI excels at making sense of information. Health Data Analytics Institute (HDAI) is a living proof — its AI-powered platform analyzes over a billion affected person encounters to enhance well being care outcomes. After a number of years of working quietly beneath the radar, the corporate as we speak revealed that it has raised $16 million, which it can use to launch an API that widens entry to its medical prediction service.
HDAI founder and CEO Nassib Chamoun says the corporate is already collaborating with organizations to measure the affect of its soon-to-be-expanded platform. HDAI lately acquired funding from the Robert Wood Johnson Foundation to assist a challenge that may analyze demand for long-term care. Separately, it’s working with New England Baptist Hospital to check the effectiveness of surgical and nonsurgical choices for spinal procedures. It’s additionally partnering with the Cleveland Clinic to match sufferers with the suitable stage of presurgical assist, utilizing AI. And HDAI plans to group up with Houston Methodist to check medical purposes that might use its danger predictors.
“Our goal is to democratize access to artificial intelligence (AI) in health care, to make it available and as easy to use for as many organizations and individuals as possible,” stated Chamoun, beforehand govt vp at well being care merchandise startup Covidien, which was acquired by Medtronic in 2015. “Over the last year, health care providers have dramatically increased their investment in deploying AI. We’re focused on helping these organizations scale quickly without taking on unnecessary work.”
HDAI’s product — which has its roots in tutorial research courting again to 2002 — affords predictors for a spread of medical and monetary outcomes, from in-hospital issues and mortality danger to whole price of care and dangers of creating persistent situations. The firm says it will possibly apply its predictive mannequin, which was educated on knowledge from over 100 million folks within the U.S. and over 20 years of follow-up information, to affected person knowledge from each paper charts and digital well being information. Furthermore, it says the mannequin can generalize throughout geographies and populations and may seize new info as people and populations age.
Beyond its well being system pilots and research, HDAI works with carriers to determine insurance coverage merchandise for particular person clients and their households. It additionally furnishes pharmaceutical purchasers with details about which medicine may work, how effectively, and for which sufferers.
HDAI’s work in predictive medication is on-trend — the worldwide AI in medication market was valued at $719 million in 2017, in accordance with Allied Markets Research. Spring Health has raised $22 million to broaden its AI service that matches customers with a psychological well being therapy plan. Clew Medical launched a predictive analytics platform to assist forestall life-threatening issues for sufferers. Charlotte, North Carolina- and Santa Clara-based LeanTaaS snagged $40 million for AI-imbued merchandise that ostensibly optimize well being clinic operations. And KenSci nabbed $22 million for its AI-driven prediction platform that helps practitioners lower prices intelligently by figuring out contributing medical and monetary components.
But Invus managing director Philippe Amouyal says what’s compelling about HDAI is its “pragmatic” deal with making use of AI to assist enhance medical follow as we speak, not within the distant future. “Our involvement with HDAI stems from our belief that their platform has the potential to become a fundamental analytics layer that improves care,” he added. “[It provides] a rigorous quantification of patient risk to inform clinical judgment.”
HDAI relies in Dedham, Massachusetts and has about 25 staff. Current and former buyers embrace Invus and QuantRes founder Harald McPike.